Josh Enomoto

Josh Enomoto

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

10 Marijuana Stocks for the Canadian ‘Pot Rush’

With Canada’s move to fully legalize cannabis now official, the message is clear: Marijuana stocks are the next big thing.

3 Reasons I’m Cautious Against Twilio Stock

Twilio stock is one of tech’s biggest revelations of 2018, but a questionable acquisition and a tough market clouds future prospects.

Netflix Stock Needs Strong Sub Growth to Move Higher

Regardless of how Netflix stock moves, patient investors can benefit from NFLX developing a strong foundation for international growth.

7 Master Limited Partnerships to Buy Despite Rising Rates

While safe, passive-income-generating assets have become more attractive recently, MLPs still offer far superior returns.

The Market’s Latest Beating Has Brought Out the Best in IBM Stock

IBM stock has long played the laggard, but when the markets are in freefall, this generously yielding company is the perfect hedge.

I’m Not Convinced By Wells Fargo’s Earnings

The markets boosted Wells Fargo stock after the banking giant posted some positive results, but we need to see much more.

Comcast Stock Has Become Wall Street’s Quicksand

Comcast stock has now accelerated its irrelevancy due to the Sky buyout, which largely features yesteryear “benefits".

5 Reasons to Buy Facebook Stock Despite Market Volatility

Facebook stock was one of several investments that got steamrolled midweek, but among contrarian opportunities, FB is your go-to pick.

The Gut-Punch to Apple Stock Is Only the Start of the Beating to Come

AAPL stock took a beating along with the rest of the markets, but investors should avoid scratching the contrarian itch on Apple for now.

5 Healthcare Stocks to Buy for Complete Portfolio Wellness

Thanks to advancing technologies and a generally positive economy, healthcare stocks are back in the limelight.